Atlas Trials

Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg

Clinical trial NCT02593500 · COMPLETED

Trial details

NCT number
NCT02593500
Sponsor
Reig Jofre Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergy
Start date
2014-04-01
Primary completion
2014-05-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.